Hims & Hers Health, Inc. (HIMS) insider trading

By person

16 insiders · 2 transactions

63.3×

Mr. Dudum holds 63.3 times base salary in stock. $31.37M of shares against $494.79K in salary for 2025.

Salary from the company's own proxy. The shares are what Mr. Dudum last reported holding, valued at $27.60, the price Class A Common Stock was last bought or sold at on the open market here, on 28 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Soleil Boughton

Chief Legal Officer

—

$196.13K (2) scheduled

−$196.13K

293,886

0.127%

$8.11M

+72.9%

Andrew Dudum

Chief Executive Officer

—

1,136,583

0.490%

$31.37M

−66.0%

Melissa Baird

Chief Operating Officer

—

805,083

0.347%

$22.22M

+27.6%

Michael Chi

Chief Operating Officer

—

456,660

0.197%

$12.60M

+133.1%

Oluyemi Okupe

Chief Financial Officer

—

242,380

0.105%

$6.69M

+61.9%

David B Wells

Director

—

229,808

0.099%

$6.34M

+17.2%

Patrick Harrison Carroll

Chief Medical Officer

—

197,847

0.085%

$5.46M

−7.3%

Mohamed Elshenawy

CTO

—

185,556

0.080%

$5.12M

—

Garcia Andrea G Perez

Director

—

83,822

0.036%

$2.31M

+15.2%

Delos M. Cosgrove

Director

—

67,995

0.029%

$1.88M

+25.0%

Christiane Pendarvis

Director

—

55,430

0.024%

$1.53M

+131.8%

Deborah M. Autor

Chief Policy Officer

—

48,961

0.021%

$1.35M

—

Anja Manuel

Director

—

38,671

0.017%

$1.07M

—

Christopher D Payne

Director

—

34,863

0.015%

$962.22K

—

Kare Schultz

Director

—

26,020

0.011%

$718.15K

—

Irene Becklund

PAO

—

13,985

0.006%

$385.99K

+173.4%

Hims & Hers Health, Inc.

What the insiders did Scheduled selling only

By person